Transdermal Peptide TD-1
Transdermal Peptide TD-1
Product description
Transdermal Peptide TD-1 is novel peptide designed to enhance transdermal drug delivery. Mechanistic studies suggest that the peptide creates transient opening in the skin barrier, which enables protein-sized molecules to pass through the skin and reach systemic circulation. When TD-1 is co-administrated with insulin on rat skin, systemic levels of insulin and human growth hormone are increased significantly.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Sequence | H-Ala-Cys-Ser-Ser-Ser-Pro-Ser-Lys-His-Cys-Gly-OH (disulfide bridge) |
| One letter sequence | ACSSSPSKHCG (disulfide bridge) |
| Molecular Formula | C40H66N14O16S2 |
| Storage | -20℃,protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Transdermal Peptide TD-1
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


